Topic 17 - Mycetism: mushroom poisonings in humans Flashcards
(40 cards)
Mycetism
Health hazard caused by ingestion of toxic substances present in macro fungal sporocarps
Mycetisms of animals
Little is known
Livestock usually not treated, if poisoned →slaughter
Pets meet rarely with macrofungal sporocarps
Susceptibility of wild animals to fungal poisoning poorly studied
Mycetism in humans
Macrofungal poisonings with a long latency period
Phalloides syndrome
Orellanus syndrome
Gyromitra toxicity
Mycetism in humans
Macrofungal poisonings with a short latency period (hallucinogenic fungi)
Muscarinic syndrome
Pantherina syndrome
Psilocybin syndrome
Other macrofungal poisonings
Disulfiram syndrome
Paxillus syndrome
Gastrointestinal syndrome
Consumption of raw mushrooms
Phalloides syndrome: symptoms and poisonous compounds
Latency period: 6-24 hours
Starts with stomach complaints → vomiting and diarrhoea (fever) → high risk of dehydration (gastrointestinal phase)
Acute symptoms end within 1-2 days, but continue with liver damages, liver enlargement, jaundice, haemorrhages in the stomach and intestines, and disturbance of consciousness
Toxic compounds of phalloides syndrome
Amatoxins, phallatoxins, virotoxins
Death cap poisoning: mechanism of action
Toxins can inactivate the RNA polymerase II enzyme and terminate the protein synthesis at the level of transcription → hepatocytes die
Phallotoxins and virotoxins
Less toxic (worse absorption rate in the tissues)
Phallotoxins inhibit cell division and destroy cell membranes
Virotoxins supposed to have effects similar to that of phallotoxins
Lethal dose of death cap poisoning
LD50 for humans: 0.1 mg/bwkg
A single sporocarop of 20-25 g of A. phalloides contains 5-8 mg of amatoxins
Treatment of death cap poisoning
Removal of toxins from the intestinal tract and the blood must be immediately started after the appearance of the first symtoms → inhibition of liver toxicity → Recovery of electrolyte metabolism of body
Detoxification of blood
Chemotherapy
Transplantation of liver
Detoxification of blood
By hemodialysis and plasmaphoresis
Chemotherapy
Various liver defences: application of lipoic acid, cytochrome C, silymarin, high dose antibiotics, and vitamin C
Taxa causing Orellanus syndrome
Cortinarius orellanus (fool’s webcap) C. orellanoides C. rubellus (deadly webcap) C. splendens (cortinarin) C. gentilis C. fluorescens ...
Orellanus syndrome symptoms
Long latency (2-17 days), symptoms not always associated with the idea of mushroom poisoning
Repeated mushroom ingestion → toxins accumulated in the tissues
Initial symptoms: anorexia, fatigue, headache, thirst, chills, high fever, GI symptoms
Later symptoms: pain in joints, lumbar region, muscles, kidney damage, and less frequent: liver damage and manifestation of nervous system
Final outcome: kidney faliure, death
Cause of orellanus syndrome
Orellanin
- colorless
- Fluoresces in blue
- has bipyridyl structure
- has been detected from the renal tubules, highly probable to affect them
Treatment of orellanus syndrome
Symptomatic treatment of kidneys
Dialysis
Transplatnation of kidneys
Prevention of orellanus syndrome
little is knownabout the toxins of Cortinarius species hence, the consumption of all the related taxa should be avoided
Taxa causing Gyromitra toxicity
Gyromitra esculenta(false morel) G. fastigiata(brown false morel) G. gigas(snow morel) G. infula (hooded false morel) Cudonia circinans Helvellaspp. (elfin saddles) Discinaspp.
Gyromitra toxicity symptoms
Two-phase course
Long latency period
Starts with GI symptoms (nausea, abdominal pain, vomiting, diarrhoea, headache)
May lead to liver damages and nervous system symptoms (nervousness, excitement, delirium)
2-3 days → circulation system of the patient may collapse; death is often due to respiratory failure
Gyromitrin: mechanism of action
Thermo-instable compound
Serious poisoning may happen only when large amounts of raw mushrooms are ingested
Liver → transformed into monomethyl hydrazine
Inhibit enzymes; are teratogenic, mutagenic and carcinogenic effects have also been shown
Treatment of gyromitra toxicity
Similar to death cap poisoning
vitamin B used to support liver
Muscarinic syndrome - muscarine mechanism of action
Muscarine → structural analog of acetylcholine: able to bind to all types of muscarinic acetylcholine receptors and activate them
Parasympathetic nervous system uses chiefly acetylcholine as its neurotransmitter → muscarine causes parasympathetic predominance
Symptoms of muscarinic syndrome
Short latency period
Characteristic parasympathetic neurological symptoms (perspiration, salivation, lacrimation) can be observed with a low heart rate and blood pressure, and narrowpupils
Other symptoms: shortness of breath, visual disturbances